The DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Gastrointestinal symptoms and nutritional issues in patients with hypermobility disorders: assessment, diagnosis and management
Open accessAbstract
Patients diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders are increasingly presenting to secondary and tertiary care centres with gastrointestinal (GI) symptoms and nutritional issues. Due to the absence of specific guidance, these patients are investigated, diagnosed and managed heterogeneously, resulting in a growing concern that they are at increased risk of iatrogenic harm. This review aims to collate the evidence for the causes of GI symptoms, nutritional issues and associated conditions as well as the burden of polypharmacy in this group of patients. We also describe evidence-based strategies for management, with an emphasis on reducing the risk of iatrogenic harm and improving multidisciplinary team care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the existing evidence is primarily drawn from retrospective studies at tertiary centres, leaving the true prevalence uncertain [37].”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [37]
In the citing paper
“and these rates then increase with age [37].”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [37]
In the citing paper
“Gastrointestinal symptoms are highly prevalent in patients with hEDS/HSD, with prevalence rates for at least one gastrointestinal symptom ranging from 30% to 96% [37], and these rates then increase with age [37].”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [37]
In the citing paper
“hEDS/HSD may be associated with altered gastrointestinal innervation as reflected by, for example, gastrointestinal dysmotility; however, the existing evidence is primarily drawn from retrospective studies at tertiary centres, leaving the true prevalence uncertain [37].”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [37]
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Psychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936
Trends in Opioid Analgesic Abuse and Mortality in the United States
Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406143 · Cited by 1,137
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Management of functional somatic syndromes
Henningsen, P., Zipfel, S., & Herzog, W. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60159-7 · Cited by 741
Mast Cell Function: A New Vision of an Old Cell
da Silva, E. Z. M., Jamur, M. C., & Oliver, C. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414545334 · Cited by 604
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Self-citationDrossman, D. A., Tack, J., Ford, A. C., Szigethy, E., Törnblom, H., & Van Oudenhove, L. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.279 · Cited by 470
Shaw, B. H., Stiles, L. E., Bourne, K., Green, E. A., Shibao, C. A., Okamoto, L. E., Garland, E. M., Gamboa, A., Diedrich, A., Raj, V., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12895 · Cited by 326
Research works printed but not linked: 1
- Abdul- Razakq, 2021, No increase in oesophageal dysmotility or hiatus hernias in patients with hypermobility spectrum disorders and dysphagia compared to non-hypermobile controls: a two-centre case-control study, Neurogastroenterol Motil, 33, 49
Cited by
Aziz, Q., Harris, L. A., Goodman, B. P., Simrén, M., & Shin, A. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.02.015 · Cited by 27
Alarfaj, N. A., Alshehri, E. M., Al-Tamimi, S. A., & El-Tohamy, M. F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26164 · Cited by 11
“Examples include histamine (H2) receptor antagonists, proton pump inhibitors, and antisecretory agents [1].”
BackgroundLal, S., Paine, P., Tack, J. F., Aziz, Q., Barazzoni, R., Cuerda, C., Jeppesen, P. B., Joly, F., Lamprecht, G., Mundi, M. S., et al. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14853 · Cited by 8
“23 This may be particularly important since anecdotal clinical experience suggests that HPN-related CRBSI are more frequent in this patient cohort.”
Self-citationLal, S., Paine, P., Tack, J. F., Aziz, Q., Barazzoni, R., Cuerda, C., Jeppesen, P. B., Joly, F., Lamprecht, G., Mundi, M. S., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.05.027 · Cited by 13
Self-citationRetractedMast cell activation and nutritional disorders in patients with hypermobility
Penny, H. A., Aziz, I., & Lam, C. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001008 · Cited by 6
“Evidence-based treatment options for coexistent organic gastrointestinal disease and DGBIs in patients with hEDS/HSDs have been extensively reviewed elsewhere [39 ].”
BackgroundSelf-citation
Metadata
- Authors
- Lam, C., Amarasinghe, G., Zarate-Lopez, N., Fikree, A., Byrne, P., Kiani-Alikhan, S., Gabe, S., & Paine, P.
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- London North West Healthcare NHS Trust (GB)
- Gastoenterology and GI physiology, University College London Hospitals NHS Foundation Trust, London, UK
- Barts Health NHS Trust (GB)
- East London NHS Foundation Trust (GB)
- Immunology Barts Health NHS Trust, London, UK
- Salford Royal NHS Foundation Trust (GB)
- Corresponding author
- Paine, Peter
- Venue
- Frontline Gastroenterology
- Publisher
- BMJ
- Published
- 2022-06-08
- Volume
- 14
- Issue
- 1
- Pages
- 68-77
- ISSN
- 2041-4137 (ISSN-L)
- 2041-4145
- PMC
- PMC9763642
- OpenAlex
- W4293078239
- Cited by
- 23
- References
- 67
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 7 · 2023: 2 · 2022: 1
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Frontline Gastroenterology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Keywords
- hypermobility Ehlers-Danlos syndrome, gastrointestinal symptoms, polypharmacy, iatrogenic injury, multidisciplinary care, diagnosis and management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gastrointestinal symptoms and nutritional issues in patients with hypermobility disorders: assessment, diagnosis and management. https://app.cochat.ai/papers/10.1136/flgastro-2022-102088
- The paper
- Lam, C., Amarasinghe, G., Zarate-Lopez, N., Fikree, A., Byrne, P., Kiani-Alikhan, S., Gabe, S., & Paine, P. (2023). Gastrointestinal symptoms and nutritional issues in patients with hypermobility disorders: assessment, diagnosis and management. Frontline Gastroenterology. https://doi.org/10.1136/flgastro-2022-102088
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.